Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
14.75
-0.58 (-3.78%)
Jun 11, 2026, 3:04 PM CST

SHE:002932 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
776.81510.9493.911,0162,5561,190
Short-Term Investments
-2,980850.86102.4370-
Trading Asset Securities
2,075394.3564.12122.591,953700
Cash & Short-Term Investments
2,8523,8851,4091,2414,5781,890
Cash Growth
-11.56%175.74%13.56%-72.90%142.22%117.48%
Accounts Receivable
448.83469.98766.951,2542,736740.42
Other Receivables
56.5113.5380.5270.2817.5211.97
Receivables
505.33583.5847.471,3242,754752.39
Inventory
95.7165.182.3128.77258.44284.59
Other Current Assets
1,246149.4759.0256.491.0972.98
Total Current Assets
4,6994,6832,3982,7507,6823,000
Property, Plant & Equipment
649.96632.16721.68543.6525.97243.47
Long-Term Investments
247.07247.07257.61156.3683.4960.62
Other Intangible Assets
31.3626.5417.317.716.8616.59
Long-Term Deferred Tax Assets
212.23212.44216.9210.18173.9516.63
Long-Term Deferred Charges
6.432.13.1114.8717.211.45
Other Long-Term Assets
152.38177.052,9793,694695.3378.24
Total Assets
6,0195,9806,5937,3879,1953,417
Accounts Payable
98.2581.32278.11681.581,294174.31
Accrued Expenses
36.3248.6787.97154.94364.6883.18
Short-Term Debt
122323.61164.6730
Current Portion of Leases
1.962.544.37.2918.173.62
Current Income Taxes Payable
1.910.346.446.27144.02131.8
Current Unearned Revenue
31.921.4937.9653.17309.5871.18
Other Current Liabilities
73.7584.6478.0792.569.9651.9
Total Current Liabilities
256.07240.99495.861,0192,365545.98
Long-Term Leases
10.313.195.8218.2520.7510.74
Long-Term Unearned Revenue
26.526.520.8714.265.965.96
Long-Term Deferred Tax Liabilities
53.8352.7650.4239.5931.074.33
Other Long-Term Liabilities
1.141.141.443.03--
Total Liabilities
347.84324.56574.41,0942,423567.02
Common Stock
232.52232.52232.52232.52156.19104.88
Additional Paid-In Capital
818.1818.1818.1820.18887.89904.5
Retained Earnings
4,7344,7345,0144,9735,4721,812
Treasury Stock
-248.61-247.96-237.95--16.02-32.77
Comprehensive Income & Other
-8.34-8.34----
Total Common Equity
5,5275,5285,8266,0266,5002,789
Minority Interest
143.75127.33192.29266.21271.9261.25
Shareholders' Equity
5,6715,6566,0196,2926,7722,850
Total Liabilities & Equity
6,0195,9806,5937,3879,1953,417
Total Debt
24.267.7213.1149.16203.5944.36
Net Cash (Debt)
2,8273,8771,3961,1924,3751,846
Net Cash Growth
-11.96%177.78%17.14%-72.76%137.02%153.67%
Net Cash Per Share
12.8816.496.185.2519.038.72
Filing Date Shares Outstanding
219.45219.49220.05232.52232.73232.84
Total Common Shares Outstanding
219.45219.49220.05232.52232.73232.84
Working Capital
4,4434,4421,9021,7315,3172,454
Book Value Per Share
25.1925.1926.4825.9227.9311.98
Tangible Book Value
5,4755,5025,8096,0086,4832,772
Tangible Book Value Per Share
24.9525.0726.4025.8427.8611.91
Buildings
-496.88440.3116.98116.6678
Machinery
-394.69380.8402.91374.05158.18
Construction In Progress
--120.79185.19121.5273.58